Search Results 211-220 of 15890 for Residual
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual ... Residual Disease (pCR)- (PHASE ...
Rochester, Minn. A growing body of research demonstrates a correlation between residual corticospinal connectivity and severity of spasticity following SCI ( ...
... residual disease and tissue at the time of any breast cancer recurrence. ... Collection of tissue and blood from patients with residual disease after neoadjuvant ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...
The idea is to boost T cell activity and mop up any residual cancer. Says Dr. Knutson, “If the tumor starts to come back, you'll have primed T cells ready ...
To access residual muscle specimens from diagnostic muscle biopsies obtained as part of the routine medical care. The biospecimens will be used to better ...
These cells include T lymphocytes that seem to be more than simple residual elements from the normal lymph node structure. A high number of intratumoral T ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.